- Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS2004 | Third Faculty of Medicine
- Number of severe bleeding complications according to classification used: Is unified classification of bleeding complications really necessary?2015 | Third Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen, First Faculty of Medicine
- Restoration Libertines and the Clash of their Weltanschauungen: Reason, Faith, and Human Nature in Buckingham's and Rochester's Writings2020 | Faculty of Arts
- The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA.CER) trial: study design and rationale2009 | Third Faculty of Medicine
- Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial2019 | Publication without faculty affiliation
- Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy2013 | Third Faculty of Medicine
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention2017 | Publication without faculty affiliation
- Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial2013 | Third Faculty of Medicine
- Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIXPublication without faculty affiliation
